|
1
|
Mansel RE, Fallowfield L, Kissin M, Goyal
A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny
I, et al: Randomized multicenter trial of sentinel node biopsy
versus standard axillary treatment in operable breast cancer: The
ALMANAC trial. J Natl Cancer Inst. 98:599–609. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krag DN, Weaver DL, Alex JC and Fairbank
JT: Surgical resection and radiolocalization of the sentinel lymph
node in breast cancer using a gamma probe. Surg Oncol. 2:335–340.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Giuliano AE, Kirgan DM, Guenther JM and
Morton DL: Lymphatic mapping and sentinel lymphadenectomy for
breast cancer. Ann Surg. 220:391–401. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kitai T, Inomoto T, Miwa M and Shikayama
T: Fluorescence navigation with indocyanine green for detecting
sentinel lymph nodes in breast cancer. Breast Cancer. 12:211–215.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahmed M, Purushotham AD and Douek M: Novel
techniques for sentinel lymph node biopsy in breast cancer: A
systematic review. Lancet Oncol. 15:e351–e362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sugie T, Ikeda T, Kawaguchi A, Shimizu A
and Toi M: Sentinel lymph node biopsy using indocyanine green
fluorescence in early-stage breast cancer: A meta-analysis. Int J
Clin Oncol. 22:11–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; PRISMA Group, : Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. Ann Intern Med.
151:264–269, W64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schaafsma BE, Verbeek FP, Rietbergen DD,
van der Hiel B, van der Vorst JR, Liefers GJ, Frangioni JV, van de
Velde CJ, van Leeuwen FW and Vahrmeijer AL: Clinical trial of
combined radio and fluorescence guided sentinel lymph node biopsy
in breast cancer. Br J Surg. 100:1037–1044. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Huang L, Wang N and Chen P:
Indocyanine green detects sentinel lymph nodes in early breast
cancer. J Int Med Res. 45:514–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sugie T, Kinoshita T, Masuda N, Sawada T,
Yamauchi A, Kuroi K, Taguchi T, Bando H, Yamashiro H, Lee T, et al:
Evaluation of the clinical utility of the ICG fluorescence method
compared with the radioisotope method for sentinel lymph node
biopsy in breast cancer. Ann Surg Oncol. 23:44–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Samorani D, Fogacci T, Panzini I, Frisoni
G, Accardi FG, Ricci M, Fabbri E, Nicoletti S, Flenghi L, Tamburini
E, et al: The use of indocyanine green to detect sentinel nodes in
breast cancer: A prospective study. Eur J Surg Oncol. 41:64–70.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stoffels I, Dissemond J, Pöppel T,
Schadendorf D and Klode J: Intraoperative fluorescence imaging for
sentinel lymph node detection: Prospective clinical trial to
compare the usefulness of indocyanine green vs technetium Tc 99m
for identification of sentinel lymph nodes. JAMA Surg. 150:617–623.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji Y, Luo N, Jiang Y, Li Q, Wei W, Yang H
and Liu J: Clinical utility of the additional use of blue dye for
indocyanine green for sentinel node biopsy in breast cancer. J Surg
Res. 215:88–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grischke EM, Röhm C, Hahn M, Helms G,
Brucker S and Wallwiener D: ICG fluorescence technique for the
detection of sentinel lymph nodes in breast cancer: Results of a
prospective open-label clinical trial. Geburtshilfe Frauenheilk.
75:935–940. 2015. View Article : Google Scholar
|
|
16
|
Tong M, Guo W and Gao W: Use of
fluorescence imaging in combination with patent blue dye versus
patent blue dye alone in sentinel lymph node biopsy in breast
cancer. J Breast Cancer. 17:250–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wishart GC, Loh SW, Jones L and Benson JR:
A feasibility study (ICG-10) of indocyanine green (ICG)
fluorescence mapping for sentinel lymph node detection in early
breast cancer. Eur J Surg Oncol. 38:651–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sugie T, Sawada T, Tagaya N, Kinoshita T,
Yamagami K, Suwa H, Ikeda T, Yoshimura K, Niimi M, Shimizu A and
Toi M: Comparison of the indocyanine green fluorescence and blue
dye methods in detection of sentinel lymph nodes in early-stage
breast cancer. Ann Surg Oncol. 20:2213–2218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hirano A, Kamimura M, Ogura K, Kim N,
Hattori A, Setoguchi Y, Okubo F, Inoue H, Miyamoto R, Kinoshita J,
et al: A comparison of indocyanine green fluorescence imaging plus
blue dye and blue dye alone for sentinel node navigation surgery in
breast cancer patients. Ann Surg Oncol. 19:4112–4116. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van der Vorst JR, Schaafsma BE, Verbeek
FP, Hutteman M, Mieog JS, Lowik CW, Liefers GJ, Frangioni JV, van
de Velde CJ and Vahrmeijer AL: Randomized comparison of
near-infrared fluorescence imaging using indocyanine green and
99(m) technetium with or without patent blue for the sentinel lymph
node procedure in breast cancer patients. Ann Surg Oncol.
19:4104–4111. 2012. View Article : Google Scholar
|
|
21
|
Jung SY, Kim SK, Kim SW, Kwon Y, Lee ES,
Kang HS, Ko KL, Shin KH, Lee KS, Park IH, et al: Comparison of
sentinel lymph node biopsy guided by the multimodal method of
indocyanine green fluorescence, radioisotope, and blue dye versus
the radioisotope method in breast cancer: A randomized controlled
trial. Ann Surg Oncol. 21:1254–1259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hojo T, Nagao T, Kikuyama M, Akashi S and
Kinoshita T: Evaluation of sentinel node biopsy by combined
fluorescent and dye method and lymph flow for breast cancer.
Breast. 19:210–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hutteman M, Mieog JS, van der Vorst JR,
Liefers GJ, Putter H, Löwik CW, Frangioni JV, van de Velde CJ and
Vahrmeijer AL: Randomized, double-blind comparison of indocyanine
green with or without albumin premixing for near-infrared
fluorescence imaging of sentinel lymph nodes in breast cancer
patients. Breast Cancer Res Treat. 127:163–170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Verbeek FP, Troyan SL, Mieog JS, Liefers
GJ, Moffitt LA, Rosenberg M, Hirshfield-Bartek J, Gioux S, van de
Velde CJ, Vahrmeijer AL and Frangioni JV: Near-infrared
fluorescence sentinel lymph node mapping in breast cancer: A
multicenter experience. Breast Cancer Res Treat. 143:333–342. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ballardini B, Santoro L, Sangalli C,
Gentilini O, Renne G, Lissidini G, Pagani GM, Toesca A, Blundo C,
del Castillo A, et al: The indocyanine green method is equivalent
to the 99mTc-labeled radiotracer method for identifying the
sentinel node in breast cancer: A concordance and validation study.
Eur J Surg Oncol. 39:1332–1336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pitsinis V, Provenzano E, Kaklamanis L,
Wishart GC and Benson JR: Indocyanine green fluorescence mapping
for sentinel lymph node biopsy in early breast cancer. Surg Oncol.
24:375–379. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Polom K, Murawa D, Nowaczyk P, Rho YS and
Murawa P: Breast cancer sentinel lymph node mapping using near
infrared guided indocyanine green and indocyanine green-human serum
albumin in comparison with gamma emitting radioactive colloid
tracer. Eur J Surg Oncol. 38:137–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo W, Zhang L, Ji J, Gao W, Liu J and
Tong M: Evaluation of the benefit of using blue dye in addition to
indocyanine green fluorescence for sentinel lymph node biopsy in
patients with breast cancer. World J Surg Oncol. 12:2902014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Murawa D, Hirche C, Dresel S and Hünerbein
M: Sentinel lymph node biopsy in breast cancer guided by
indocyanine green fluorescence. Br J Surg. 96:1289–1294. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mieog JS, Troyan SL, Hutteman M, Donohoe
KJ, Van Der Vorst JR, Stockdale A, Liefers GJ, Choi HS,
Gibbs-Strauss SL, Putter H, et al: Toward optimization of imaging
system and lymphatic tracer for near-infrared fluorescent sentinel
lymph node mapping in breast cancer. Ann Surg Oncol. 18:2483–2491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kusano M, Kokudo N, Toi M and Kaibori M:
ICG fluorescence imaging and navigation surgery. Springer; Japan:
2016, View Article : Google Scholar
|
